Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in extensive-stage small cell lung cancer: a real-world retrospective analysis
The combination of cTRT with immunochemotherapy for ES-SCLC showed improved rwPFS and OS, indicating potential benefit in this population. The overall safety profile remained manageable. These findings highlight the need for further prospective studies to confirm the optimal integration of cTRT in ES-SCLC treatment strategies.
Authors
- Hongfu Sun (ORCID: https://orcid.org/0000-0003-3436-7831)
- Qian Wang (ORCID: https://orcid.org/0000-0003-3270-3248)
- Minghui Wang (ORCID: https://orcid.org/0000-0001-9171-4962)
- Xiaomeng Liu (ORCID: https://orcid.org/0000-0003-1463-9916)
- Qi Zhang (ORCID: https://orcid.org/0000-0002-6096-0690)
- Dan Han (ORCID: https://orcid.org/0000-0002-5682-5058)
- Chengwei Zhao
- Chengxin Liu (ORCID: https://orcid.org/0000-0003-2962-0820)
Institutions
- Shandong University of Aeronautics (CN)
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/jtd-24-1592
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00